|
|
||||||||


* Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; and
Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom
Human NK cells can respond rapidly to Plasmodium falciparum-infected RBC (iRBC) to produce IFN-
. In this study, we have examined the heterogeneity of this response among malaria-naive blood donors. Cells from all donors become partially activated (up-regulating CD69, perforin, and granzyme) upon exposure to iRBC but cells from only a subset of donors become fully activated (additionally up-regulating CD25, IFN-
, and surface expression of lysosomal-associated membrane protein 1 (LAMP-1)). Although both CD56dim and CD56bright NK cell populations can express IFN-
in response to iRBC, CD25 and LAMP-1 are up-regulated only by CD56dim NK cells and CD69 is up-regulated to a greater extent in this subset; by contrast, perforin and granzyme A are preferentially up-regulated by CD56bright NK cells. NK cells expressing IFN-
in response to iRBC always coexpress CD69 and CD25 but rarely LAMP-1, suggesting that individual NK cells respond to iRBC either by IFN-
production or cytotoxicity. Furthermore, physical contact with iRBC can, in a proportion of donors, lead to NK cell cytoskeletal reorganization suggestive of functional interactions between the cells. These observations imply that individuals may vary in their ability to mount an innate immune response to malaria infection with obvious implications for disease resistance or susceptibility.
This article has been cited by other articles:
![]() |
D. S. Korbel, P. J. Norman, K. C. Newman, A. Horowitz, K. Gendzekhadze, P. Parham, and E. M. Riley Killer Ig-Like Receptor (KIR) Genotype Predicts the Capacity of Human KIR-Positive CD56dim NK Cells to Respond to Pathogen-Associated Signals J. Immunol., May 15, 2009; 182(10): 6426 - 6434. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Kim, S. Parikh, J. C. Sun, A. Myrick, L. L. Lanier, P. J. Rosenthal, and J. L. DeRisi Experimental Malaria Infection Triggers Early Expansion of Natural Killer Cells Infect. Immun., December 1, 2008; 76(12): 5873 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Page, D. Chaudhary, S. J. Goldman, and M. T. Kasaian Natural killer cells from protein kinase C {theta}-/- mice stimulated with interleukin-12 are deficient in production of interferon-{gamma} J. Leukoc. Biol., May 1, 2008; 83(5): 1267 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Athie-Morales, G. M. O'Connor, and C. M. Gardiner Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide J. Immunol., March 15, 2008; 180(6): 4082 - 4089. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, J. B. Sunwoo, L. Yang, T. Choi, Y.-J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. HLA alleles determine differences in human natural killer cell responsiveness and potency PNAS, February 26, 2008; 105(8): 3053 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garg, P. F. Barnes, A. Porgador, S. Roy, S. Wu, J. S. Nanda, D. E. Griffith, W. M. Girard, N. Rawal, S. Shetty, et al. Vimentin Expressed on Mycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor J. Immunol., November 1, 2006; 177(9): 6192 - 6198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walther, J. Woodruff, F. Edele, D. Jeffries, J. E. Tongren, E. King, L. Andrews, P. Bejon, S. C. Gilbert, J. B. De Souza, et al. Innate Immune Responses to Human Malaria: Heterogeneous Cytokine Responses to Blood-Stage Plasmodium falciparum Correlate with Parasitological and Clinical Outcomes J. Immunol., October 15, 2006; 177(8): 5736 - 5745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |